MARATTO

review · Journal of Psychopharmacology

Fluoroquinolones and risk of nightmares: A literature review and disproportionality analysis using individual case safety reports from Food and Drug Administration Adverse Event Reporting System database

20252 citationsOpen accessUniversité de Kinshasa (UNIKIN)

Abstract

FQs may increase the risk of nightmares. Our findings provide valuable insights for future research on their safety profile. Further research is needed to validate these findings and guide safe FQ use.

Research topics

  • Pharmacovigilance and Adverse Drug Reactions
  • Pharmaceutical studies and practices
  • Epilepsy research and treatment

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1177/02698811251344684

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.